
|Slideshows|April 7, 2022
7 New Drugs Approved for Primary Care: Q1 2022
Author(s)Sydney Jennings
Another new COVID-19 vaccine, the first and only once-daily amphetamine transdermal patch approved for the treatment of ADHD, and 5 more.
Advertisement
At the close of the first quarter of a new year, Patient Care Online has compiled a list of 7 new FDA-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on a new oral solution of amlodipine; the first and only FDA-approved, once-daily amphetamine transdermal patch for the treatment of attention deficit hyperactivity disorder; and 5 more.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Psychiatry in 2026: Emerging Therapies and Why Sleep Is Moving Up the Priority List
2
Population-Based eGFR Percentiles Linked to Kidney Failure and Mortality Risk, Study Finds
3
Adjunctive Lumateperone Nearly Doubles Remission Rates at 6 Weeks in Adults With Major Depressive Disorder
4
Weekly Dose Podcast: Needle-Free Epinephrine, Pediatric Atopic Dermatitis Gains, Smarter Dementia Screening, Teen Depression Treatment, and Oral PCSK9 Data
5






















































































































































































































































































































